𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A randomized, pilot trial of etanercept in dermatomyositis

✍ Scribed by The Muscle Study Group

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
330 KB
Volume
70
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Etanercept in Sjögren's syndrome: A twel
Etanercept in Sjögren's syndrome: A twelve-week randomized, double-blind, placebo-controlled pilot clinical trial
✍ Vidya Sankar; Michael T. Brennan; Marc R. Kok; Rose Anne Leakan; Janine A. Smith 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 1 views

## Abstract ## Objective To assess the safety and potential efficacy of etanercept in the treatment of Sjögren's syndrome (SS). ## Methods This pilot study was a 12‐week randomized, double‐blind, placebo‐controlled trial of etanercept, with 14 subjects in each group. Patients received 25 mg of e

Randomized clinical trial of lifestyle i
Randomized clinical trial of lifestyle interventions in Pima Indians: a pilot study
✍ Venkat Narayan, K.M.; Hoskin, M.; Kozak, D.; Kriska, A.M.; Hanson, R.L.; Pettitt 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 1 views

A pilot trial was conducted to test adherence to specific lifestyle interventions among Pima Indians of Arizona, and to compare them for changes in risk factors for diabetes mellitus. Ninety-five obese, normoglycaemic men and women, aged 25-54 years, were randomized to treatments named 'Pima Action'

Do memory clinics improve the quality of
Do memory clinics improve the quality of life of carers? A randomized pilot trial
✍ Dina Logiudice; Wendy Waltrowicz; Kaye Brown; Colin Burrows; David Ames; Leon FL 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

Objective. To determine the eects of attendance at a memory clinic on the psychosocial health of carers. Design. Randomized control trial. Participants. Fifty community dwelling subjects with mild to moderate dementia and their carers. Main outcome measures. Carer burden, psychological morbidity and

Recombinant human tumor necrosis factor
Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial
✍ John C. Davis Jr.; Désirée Van Der Heijde; Jurgen Braun; Maxime Dougados; John C 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

## Abstract ## Objective To determine the safety and efficacy of etanercept in a multicenter, randomized, placebo‐controlled, double‐blind trial of adults with moderate to severe active ankylosing spondylitis (AS). ## Methods Patients (n = 277) were treated with either etanercept 25 mg (n = 138)